Abstract
The ideal aortic valve implant will provide maximum restoration of aortic valve dynamics, a low transvalvular gradient, minimal long-term structural valvular degeneration, a low infection rate and will be relatively easy to implant. Stentless bioprosthetic valves have been shown to provide excellent hemodynamics in comparison to first and second generation stented bioprostheses, with corresponding early greater regression in left ventricular mass [14]. We assessed the medium term outcome of implantation of the Vascutek Elan aortic stentless bioprosthesis (Vascutek, Newmains Avenue, Inchinnan, Renfrewshire PA4 9RR, Scotland, UK) in a single center (Fig. 1).
Vascutek Elan stentless bioprosthesis
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Akar AR, Szafranek A, Alexiou C, Janas R, Jasinski MJ, Swanevelder J, Sosnowski AW (2002) Use of stentless xenografts in the aortic position: determinants of early and late outcome. Ann Thorac Surg 74:1450–1457, discussion 1457–1458
Borger MA, Carson SM, Ivanov J, Rao V, Scully HE, Feindel CM, David TE (2005) Stentless aortic valves are hemodynamically superior to stented valves during mid-term follow-up: a large retrospective study. Ann Thorac Surg 80:2180–2185
Chambers J, Rimington H, Rajani R, Hodson F, Blauth C (2004) Hemodynamic performance on exercise: comparison of a stentless and stented biological aortic valve replacement. J Heart Valve Dis 13:729–733
Chambers JB, Rimington HM, Hodson F, Rajani R, Blauth CI (2006) The subcoronary Toronto stentless versus supra-annular Perimount stented replacement aortic valve: early clinical and hemodynamic results of a randomized comparison in 160 patients. J Thorac Cardiovasc Surg 131:878–872
Dellgren G, Eriksson MJ, Brodin LA, Radegran K (2002) Eleven years’ experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate. Eur J Cardiothorac Surg 22:912–921
Desai ND, Merin O, Cohen GN, Herman J, Mobilos S, Sever JY, Fremes SE, Goldman BS, Christakis GT (2004) Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve. Ann Thorac Surg 78:2076–2083; discussion 2076–2083
Edmunds LHJ, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD (1996) Guidelines for reporting morbidity and mortality after cardiac valvular operations. Eur J Cardiothorac Surg 10:812–816
Ennker JA, Albert AA, Rosendahl UP, Ennker IC, Dalladaku F, Florath I (2008) Ten-year experience with stentless aortic valves: full-root versus subcoronary implantation. Ann Thorac Surg 85:445–452; discussion 452–453
Knosalla C, Weng Y, Yankah CA, Siniawski H, Hofmeister J, Hammerschmidt R, Loebe M, Hetzer R (2000) Surgical treatment of active infective aortic valve endocarditis with associated periannular abscess — 11 year results. Eur Heart J 21:490–497
Martinovic I, Everlien M, Farah I, Wittlinger T, Knez I, Greve H, Vogt P (2005) Midterm results after aortic valve replacement with a stentless bioprosthesis aortic valve. Ann Thorac Surg 80:198–203
Nagy ZL, Bodi A, Len A, Balogh I, Peterffy A (2005) Three years’ experience with the sorin pericarbon stentless prosthesis: mid-term results with three different implantation techniques. J Heart Valve Dis. 14:72–77
O’Brien MF, Gardner MA, Garlick B, Jalali H, Gordon JA, Whitehouse SL, Strugnell WE, Slaughter R (2005) CryoLife-O’Brien stentless valve: 10-year results of 402 implants. Ann Thorac Surg 79:757–766
Okada K, Tanaka H, Takahashi H, Morimoto N, Munakata H, Asano M, Matsumori M, Kawanishi Y, Nakagiri K, Okita Y (2008) Aortic root replacement for destructive aortic valve endocarditis with left ventricular-aortic discontinuity. Ann Thorac Surg 85:940–945
Raja SG, Macarthur KJ, Pollock JC (2006) Impact of stentless aortic valves on left ventricular function and hypertrophy: current best available evidence. J Card Surg 21:313–319
Sabik JF, Lytle BW, Blackstone EH, Marullo AG, Pettersson GB, Cosgrove DM (2002) Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 74:650–659, discussion 659
Siniawski H, Grauhan O, Hofmann M, Pasic M, Weng Y, Yankah C, Lehmkuhl H, Hetzer R (2004) Factors influencing the results of double-valve surgery in patients with fulminant endocarditis: the importance of valve selection. Heart Surg Forum 7:E405–410
Siniawski H, Lehmkuhl H, Weng Y, Pasic M, Yankah C, Hoffmann M, Behnke I, Hetzer R (2003) Stentless aortic valves as an alternative to homografts for valve replacement in active infective endocarditis complicated by ring abscess. Ann Thorac Surg 75:803–808, discussion 808
Yankah CA, Pasic M, Klose H, Siniawski H, Weng Y, Hetzer R (2005) Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study. Eur J Cardiothorac Surg 28:69–75
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Berg, G.A., Sonecki, P., Berg, R.B.S., MacArthur, K.J.D. (2010). The Vascutek Elan stentless porcine prosthesis — The Glasgow experience. In: Yankah, C.A., Weng, Y., Hetzer, R. (eds) Aortic Root Surgery. Steinkopff. https://doi.org/10.1007/978-3-7985-1869-8_28
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1869-8_28
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1868-1
Online ISBN: 978-3-7985-1869-8
eBook Packages: MedicineMedicine (R0)